Cytotoxic Gonadotropin Releasing Hormone Derivatives
Cytotoxic Gonadotropin Releasing Hormone Derivatives
批准号:
6479651
负责人:
L MICHAEL GLODE
金额:
$24.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-24 至 2004-04-30
关键词:
cell free system cell line chimeric proteins clinical research cytotoxicity expression cloning fusion gene gonadotropin releasing factor hormone receptor hormone related neoplasm /cancer human tissue messenger RNA plasmids polymerase chain reaction protein binding protein engineering protein folding protein purification receptor binding receptor expression transfection /expression vector
中文摘要
激素反应性癌症,如前列腺癌和乳腺癌,是美国老龄化人口发病率和死亡率的主要原因。这些癌症可以用性类固醇拮抗剂治疗这些化合物是昂贵的,并且会发生突变逃逸。最近的创新方法是使用激素毒素专门针对癌细胞。有几种这样的方法已经在人体临床试验中。我们之前证明了gnrh毒素偶联物选择性地杀死垂体促性腺激素。通过这种方法优化细胞死亡可以为激素反应性癌症提供一种新的单一治疗方式。在目前的建议中,我们将研究GnRH- PAP偶联物在多种癌细胞系中与融合蛋白的毒性,并将GnRH毒素与微解剖肿瘤和邻近正常组织中GnRHR mRNA表达的结合联系起来。我们假设携带受体的癌细胞在暴露于GnRH毒素时将被杀死,并且结合物将比融合蛋白更具细胞毒性。这种方法将把GnRH毒素的应用范围扩大到激素抵抗性前列腺癌和乳腺癌,以及被认为对激素没有反应但表达GnRH受体的癌症,如卵巢癌,可能还有胰腺癌和肝细胞癌。建议的商业应用:使用gnrh毒素可能提供一种单针治疗激素反应性和一些激素抵抗性癌症的方法。这将导致一种更好的、非手术的、经济有效的方法来治疗这些癌症。
英文摘要
Hormonally responsive cancers, such as prostate and breast, are a major cause of morbidity and mortality in the aging population in the United States. These cancers can be treated by sex steroid antagonists by these compounds are costly and mutational escape occurs. Recent innovative approaches have used hormonotoxins to specifically target the cancer cells. Several such approaches are already in human clinical testing. We previously demonstrated that GnRH-toxin conjugates selectively kill pituitary gonadotrophs. Optimizing cell death by this method could result in a novel, single treatment modality for hormonally responsive cancers. In the current proposal, we will look at the toxicity of GnRH- PAP conjugate to fusion protein in a variety of cancer cell lines, and will correlate binding of GnRH-toxins to GnRHR mRNA expression in microdissected tumor and adjacent normal tissue. We hypothesize that cancer cells bearing the receptor will be killed upon exposure to GnRH toxins, and that the conjugate will be more cytotoxic than the fusion protein. This approach will extend the spectrum of utility of GnRH- toxins to hormone-resistant prostate and breast cancer and to cancers not thought of as hormone-responsive which nevertheless express the GnRH receptor, such as ovarian, and possibly pancreatic and hepatocellular carcinoma. PROPOSED COMMERCIAL APPLICATIONS: Use of GnRH-toxin may provide a single-shot approach to treat hormonally responsive as well as some hormone-resistant cancers. This would result in a superior, non-surgical and cost-effective means of treating these cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and testing of a silibin-containing sunscreen
-
批准号:7210773
-
项目类别:
-
资助金额:$10.82万
-
财政年份:2007
-
负责人:L MICHAEL GLODE
-
依托单位:
Cytotoxic Gonadotropin Releasing Hormone Derivatives
-
批准号:6625863
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2002
-
负责人:L MICHAEL GLODE
-
依托单位:
MOLECULAR MARKERS FOR PROSTATE CANCER DETECTION
-
批准号:2828530
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1999
-
负责人:L MICHAEL GLODE
-
依托单位:
MOLECULAR MARKERS FOR PROSTATE CANCER DETECTION
-
批准号:6173893
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1999
-
负责人:L MICHAEL GLODE
-
依托单位:
GNRH ANALOG TOXINS FOR TARGETED GONADOTROPH ABLATION
-
批准号:2862665
-
项目类别:
-
资助金额:$24.65万
-
财政年份:1997
-
负责人:L MICHAEL GLODE
-
依托单位:
GNRH ANALOG TOXINS--USE FOR GONADOTROPH ABLATION
-
批准号:2416914
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:L MICHAEL GLODE
-
依托单位:
GNRH ANALOG TOXINS FOR TARGETED GONADOTROPH ABLATION
-
批准号:6172694
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1997
-
负责人:L MICHAEL GLODE
-
依托单位:
VECTOR SYSTEMS FOR TOXIN GENE THERAPY--OVARIAN CARCINOMA
-
批准号:2099311
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1993
-
负责人:L MICHAEL GLODE
-
依托单位:
FOREIGN GENE EXPRESSION IN MAMMALIAN CELL LINES
-
批准号:3022987
-
项目类别:
-
资助金额:$1.83万
-
财政年份:1987
-
负责人:L MICHAEL GLODE
-
依托单位:
REGULATION OF CYSTATHIONASE EXPRESSION
-
批准号:3168655
-
项目类别:
-
资助金额:$15.1万
-
财政年份:1980
-
负责人:L MICHAEL GLODE
-
依托单位:
REGULATION OF CYSTATHIONASE EXPRESSION
-
批准号:3168654
-
项目类别:
-
资助金额:$15.0万
-
财政年份:1980
-
负责人:L MICHAEL GLODE
-
依托单位:
海外基金